Molecular Partners AG (XSWX:MOLN)
CHF 3.305 -0.115 (-3.36%) Market Cap: 108.63 Mil Enterprise Value: -74.61 Mil PE Ratio: 0 PB Ratio: 0.64 GF Score: 53/100

Half Year 2019 Molecular Partners AG Earnings Call Transcript

Aug 27, 2019 / 12:00PM GMT
Release Date Price: CHF12.78 (-0.16%)
Operator

Ladies and gentlemen, welcome to the half year results 2019 conference call and live webcast. I'm Sandra, the Chorus Call operator. (Operator Instructions) And the conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to Patrick Amstutz, CEO of Molecular Partners. Please go ahead, sir.

Patrick Amstutz
Molecular Partners AG - Co-Founder, CEO, Member of Management Board & Director

Thanks for the introduction, and a very warm welcome from my side. My name is Patrick Amstutz, CEO of Molecular Partners. With me for the presentation, I have Andreas Emmenegger, our CFO; and Michael is also here with me then for the Q&A.

It's my pleasure to walk you through on the next slide, the agenda. Okay. So I will give it a start with a review and the highlights of the first half of this year. Then I will hand over to Andreas for the financial results. I will summarize with an outlook and then -- for this year and beyond, and then we will dive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot